Ticker League

Biogen (BIIB) Free Cash Flow Bridge

Pinpoint what moved Biogen's free cash flow from TTM through Q1 2025 to TTM through Q1 2026 — operating cash flow shifts and capex changes, each driver sized in dollars.

FCF YoY

+14.27%

OCF YoY

+0.36%

Capex YoY

-88.71%

FCF Conversion Δ

+12.3 pp

Free cash flow bridge for Biogen (BIIB) — TTM through Q1 2026 vs TTM through Q1 2025

Δ Free cash flow: $327.60M

FCF bridge breakdown for Biogen (BIIB) — TTM through Q1 2026 vs TTM through Q1 2025

  • Prior Free Cash Flow$2.30B
  • Operating Cash Flow$9.30M
  • Capital Expenditure$318.30M
  • Free Cash Flow$2.62B
Identity check: drivers reconcile to ΔNI within $0.00
Want to see how cash flow is built up?Cash Flow Waterfall

Frequently asked questions

Data & methodology